The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.

Neval Ete WarehamAmanda MocroftHenrik SengeløvCaspar Da Cunha-BangFinn GustafssonCarsten HeilmannMartin IversenNikolai S KirkbyAllan RasmussenSøren Schwartz SørensenJens D Lundgrennull null

Published in: Journal of cancer research and clinical oncology (2018)

We constructed a model to better predict PTLD compared to EBV DNA screening alone which could have clinical implications.

Keyphrases

epstein barr virus
hematopoietic stem cell
circulating tumor
diffuse large b cell lymphoma
cell free
single molecule
wastewater treatment
nucleic acid
circulating tumor cells